EMWA is the European Medical Writers Association, a network of professionals that represents, supports and trains medical communicators in Europe. It is a not for profit organisation that is run for its members by its members.

This website offers access to EMWA's journal Medical Writing, as well as our Freelancer and Company listing and our Jobs page advertising vacancies for both freelance and in-house medical writers and editors. If you would like more information about how to sign up to the freelancer or company list, or how to advertise your job vacancies on this website, please contact info@emwa.org.


Posted on 13 Feb 2019

2019 EMWA sponsorship and partnership options are open for booking!

Options available include single sponsorship opportunities and packages.

Read More

Posted on 12 Feb 2019

EMWA webinar on oral presentations on 28 February

Oral presentations: skills to help you survive or even shine! by John Dixon on 28 February from 14:00 to 15:00 CET.

Read More

Posted on 05 Feb 2019

Ambassador Programme Update

The Ambassador Programme has gotten off to a good start in the New Year.

Read More

Posted on 29 Jan 2019

48th EMWA Conference, 7-11 May 2019, Vienna, Austria

A programme preview is now available on the website.

Read More

Posted on 19 Jan 2019

REMINDER: Freelance Business Survey open until 31 January 2019

Participation is open to all freelance medical writers irrespective of their location or EMWA membership and your help in sharing the link to the survey within your network is much appreciated.

Read More

Posted on 19 Jan 2019

Call for new EMWA Professional Development Committee (EPDC) member

Are you looking for a new role in EMWA for 2019?

Read More

Posted on 18 Jan 2019

The first EMWA webinar of 2019 is on 24 January

Our first EMWA webinar of 2019 is on Thursday 24th of January, from 14:00-15:00 CET by Pablo Mugüerza on "Writing about state-of-the-art medicine".

Read More

Posted on 11 Jan 2019

News of interest to medical writers: clinical trial transparency and disclosure

This paper was developed by industry experts with the goal of highlighting the evolving global landscape of clinical trial transparency and disclosure with special focus on individual study and submission-related requirements.

Read More